Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.
Characteristics of Early Initiators of Oral Semaglutide for Overweight or Obesity via Telehealth
Authors:
Brooke J. Smith1; Victoria Divino2; Camilla S. Morgen3; Lauren Broffman1; Lauren Wilson2; Raoul Manalac1; Rakesh Luthra2; Rina Patel2; Sam Chai1; Louis J. Aronne4; Beverly G. Tchang4